Loading insider details...
Beta
Latest Form 4 (Jul 1, 2026): Grant/Award of 268 NVCR shares, $3.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 1, 2026 | NovoCure Ltd (NVCR) | Grant/Award | 268 | $3.0K |
| Jul 1, 2025 | NovoCure Ltd (NVCR) | Grant/Award | 833 | $12.6K |
| Jan 3, 2025 | NovoCure Ltd (NVCR) | Grant/Award | 412 | $6.1K |
| Aug 6, 2024 | NovoCure Ltd (NVCR) | Grant/Award | 1,239 | $15.2K |
| Jul 6, 2023 | NovoCure Ltd (NVCR) | Grant/Award | 367 | $12.9K |
| Jan 9, 2023 | NovoCure Ltd (NVCR) | Exercise/Conversion | 25,000 | $286.5K |
| Jul 7, 2022 | NovoCure Ltd (NVCR) | Grant/Award | 276 | $16.3K |
| Mar 7, 2022 | NovoCure Ltd (NVCR) | Grant/Award | 13,470 | $1.09M |
| Jan 12, 2022 | NovoCure Ltd (NVCR) | Grant/Award | 31 | $2.0K |
| Nov 29, 2021 | NovoCure Ltd (NVCR) | Purchase | 3,870 | $396.1K |